These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18633992)

  • 1. Production of monoclonal antibody supernatant and ascites fluid.
    Yokoyama WM
    Curr Protoc Mol Biol; 2008 Jul; Chapter 11():Unit 11.10. PubMed ID: 18633992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody supernatant and ascites fluid production.
    Yokoyama WM
    Curr Protoc Immunol; 2001 May; Chapter 2():2.6.1-2.6.9. PubMed ID: 18432770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of monoclonal antibody supernatant and ascites fluid.
    Yokoyama WM
    Curr Protoc Mol Biol; 2001 May; Chapter 11():Unit11.10. PubMed ID: 18265068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of monoclonal antibody in mouse ascitic fluid with two solid tumor-forming hybridoma cell lines.
    Hasegawa N; Watanabe M; Okano HJ; Ohno T
    Hybridoma; 1991 Oct; 10(5):647-9. PubMed ID: 1804776
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of human monoclonal antibody in mouse ascites.
    Truitt KE; Larrick JW; Raubitschek AA; Buck DW; Jacobson SW
    Hybridoma; 1984; 3(2):195-9. PubMed ID: 6480025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody production in murine ascites. II. Production characteristics.
    Jackson LR; Trudel LJ; Fox JG; Lipman NS
    Lab Anim Sci; 1999 Feb; 49(1):81-6. PubMed ID: 10090099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimal production of murine monoclonal antibodies in ascites of syngeneic mice by a single whole body irradiation].
    Witt S; Ziegler B; Klöting I; Nadrowitz R; Schmidt W; Ziegler M
    Allerg Immunol (Leipz); 1987; 33(4):259-64. PubMed ID: 2964179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of mouse hybridomas.
    Mechetner E
    Methods Mol Biol; 2007; 378():1-13. PubMed ID: 18605074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybridoma Technology.
    Hnasko RM; Stanker LH
    Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations for in vitro monoclonal antibody production.
    Peterson NC
    Res Immunol; 1998; 149(6):553-7. PubMed ID: 9835417
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for weak monoclonal antibodies in hybridoma technology.
    Leickt L; Grubb A; Ohlson S
    J Mol Recognit; 1998; 11(1-6):114-6. PubMed ID: 10076820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody production in murine ascites. I. Clinical and pathologic features.
    Jackson LR; Trudel LJ; Fox JG; Lipman NS
    Lab Anim Sci; 1999 Feb; 49(1):70-80. PubMed ID: 10090098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new, rapid, high-capacity chromatographic purification of IgG 1 monoclonal antibodies directly from mouse ascites fluid.
    Cheng PJ; Morris RE
    Transplant Proc; 1987 Feb; 19(1 Pt 1):607-9. PubMed ID: 3274826
    [No Abstract]   [Full Text] [Related]  

  • 14. Membrane-based cell culture technologies: a scientifically and economically satisfactory alternative to malignant ascites production for monoclonal antibodies.
    Marx U
    Res Immunol; 1998; 149(6):557-9. PubMed ID: 9835418
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo and in vitro production of monoclonal antibodies: current possibilities and future perspectives. Discussion.
    Hendriksen CF; de Leeuw WA
    Res Immunol; 1998; 149(6):611-20. PubMed ID: 9835427
    [No Abstract]   [Full Text] [Related]  

  • 16. Culturing hybridoma cell lines for monoclonal antibody production.
    Winzeler A; Wang JT
    Cold Spring Harb Protoc; 2013 Jul; 2013(7):640-2. PubMed ID: 23818668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro production of monoclonal antibodies: current possibilities and future perspectives. Introduction.
    de Geus B; Hendriksen CF
    Res Immunol; 1998; 149(6):533-4. PubMed ID: 9835413
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation of human monoclonal antibodies binding to B fragment of diphtheria toxin.
    Gupta KC; Agha R; Santos E; Brodeur BR
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):25-31. PubMed ID: 1576320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some ascites monoclonal antibody preparations contain contaminants that bind to selected Golgi zones or mast cells.
    Spicer SS; Spivey MA; Ito M; Schulte BA
    J Histochem Cytochem; 1994 Feb; 42(2):213-21. PubMed ID: 7507139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of anticancer human monoclonal antibody--establishment of human monoclonal antibody to gastric cancer by human-mouse hybridoma].
    Liu H
    Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):242-4. PubMed ID: 3248478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.